Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerReduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancerKrt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.The interconnectedness of cancer cell signaling.Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.Bcl-xL promotes metastasis independent of its anti-apoptotic activity.Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor PhenotypeMechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis.The PR status of the originating cell of ER/PR-negative mouse mammary tumors.Generation and characterization of a breast carcinoma model by PyMT overexpression in mammary epithelial cells of tree shrew, an animal close to primates in evolution.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationHyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
P2860
Q24628746-4EEFE758-51DD-4B87-AE5B-F104426DA672Q30419961-6218AACF-10FB-4360-ABA7-96BD38E45192Q33728569-0B887880-9A53-463F-B4C4-847A0FD4EE74Q35031689-08677D53-8F85-43E9-AD1C-95E333746592Q35166902-EF656A9B-198C-4E5C-B38A-B56BB71E46B2Q35669733-65112FE2-E780-4EE0-9209-6BC9043942D3Q36110157-ABC808BE-6B9D-4045-BE54-D5216DD2C233Q36395533-F310EE8F-CD94-4184-ABCD-511B34D8728FQ36528864-0318271C-39F5-4BFC-8214-9971AFC2E069Q36727086-E33D6BE0-9390-4726-8BDA-7052B47D6F36Q37416853-975C9B76-2DA6-4BE4-A18D-B6962BB98C26Q37518716-42A9700D-3039-4687-8694-797A12C2CBC0Q40239612-056C90C6-B89D-4073-9EDF-50E93E98DEEEQ41463003-F2E4442E-F39F-458C-A6FD-8D3E7A1DA352Q41879186-515B44E9-FF13-4E59-94E0-BE076C32DA72Q54978736-03D7D682-2E34-4379-A4C1-834D0CBDC568Q55431818-0855940A-8C46-4AE3-92B4-5A45BECF755C
P2860
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@ast
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@en
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@nl
type
label
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@ast
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@en
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@nl
prefLabel
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@ast
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@en
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@nl
P2093
P2860
P356
P1433
P1476
Somatic expression of PyMT or ...... pendent mammary tumorigenesis.
@en
P2093
James Forman
Jian Huang
Michael J Toneff
Parisa Sinai
Rachel Schiff
Shixia Huang
Susan Hilsenbeck
P2860
P304
P356
10.1593/NEO.10516
P577
2010-09-01T00:00:00Z